A problem has arisen in a country lauded for its efforts against HIV/AIDS, overshadowing the amazing advancements made. Ghana is experiencing a severe anti-retroviral drug shortage, which is endangering the lives of people living with HIV (PLHIV).
A crisis develops as The Missing Dose The Abacavir Lamivudine regimen, essential for daily viral suppression and general health, is now noticeably missing from numerous medical centers across the nation. As a result of this shortage, the Ghana Network of Persons Living with HIV (NAP+ Ghana) has issued an urgent alert.
The typical allocation of 3-6 months’ worth of medication has been reduced, according to Elsie Ayeh, spokesperson for NAP+ Ghana, forcing PLHIV to manage an unnerving switch to monthly dosages. People who have been receiving anti-retroviral medicine for 21 years, like Abraham Asare, are feeling the effects of this extraordinary disruption very strongly. “I received an HIV diagnosis in 2000, and I started taking treatment in 2001. I am kept alive by it. Asare bemoans the shortage, lamenting that many people won’t be able to access the prescription, which is a lifeline for him and others in similar situations.
HIV in Ghana: A Summing Up Ghana, like many other African countries, has achieved impressive strides in the fight against the HIV/AIDS pandemic. The World Health Organization (WHO) reports that Ghana’s HIV prevalence has decreased over time, and the nation has put strong policies in place to ensure that individuals who need it may obtain anti-retroviral medication (ART). Recent events, nevertheless, have complicated things and pose a risk of undoing the progress accomplished and endangering the lives of individuals who depend on these life-saving drugs.
Source: Osman | Ghana360news.com
